Cerner to launch Cerner RevElate Patient Accounting

0
1

Future patient accounting offering will come from Cerner Soarian®

Emphasis on the company’s focus on customer needs through portfolio optimization

KANSAS CITY, Missouri, Oct 06, 2021 (GLOBE NEWSWIRE) – Cerner Corporation (NASDAQ: CERN), a global leader in healthcare technology, announces Identify RevElate ™, the company’s patient accounting product that will bring new and improved capabilities to the Circler® revenue cycle management portfolio. Identify RevElate is the result of Cerner’s investment in improving patient accounting capabilities and company-wide technology optimization, an effort to best align Cerner’s powerful research and development resources with solutions most needed by caregivers around the world.

Identify RevElate is expected to reduce complexity by managing data and workflows that scale to large healthcare systems and influence clinical, billing and payment workflows. It is expected to preserve and advance the clinical capabilities of Cerner Millenium® while adding scalable business capabilities of Soarienne® Patient accounting software.

Consolidation is occurring at an increasing rate across the health sector, and To identify RevElate will help provide the flexibility to integrate data from various places of care, including newly acquired and integrated facilities that may reside on disparate healthcare IT systems.

“Cerner has worked closely with its clients to gather feedback and ideas on how our software can generate better results and improve financial strength, especially since they are under tremendous pressure to be and stay profitable, ”said Brenna Quinn, senior vice president, enterprise market solutions, Cerner. “One of the goals of Cerner’s development journey is to simplify and automate the revenue cycle through interoperability and better usability both inside and outside the product suite. Identify that we offer.

BayCare Health System, Charleston Area Medical Center and CoxHealth plan to be among the first to implement Identify RevElate. BayCare Health System, a Identify Soarian Financials client, plans to work with Cerner to elevate To identify RevElate in 2022. “The effective management of our corporate revenue cycle process is critical to the vitality of our organization. Put simply, BayCare succeeds when we deliver a quality patient experience every step of the way, from admission to final billing, ”said Lynda Gorken, Vice President, Patient Financial Services, BayCare Health System. “As a long-time Cerner customer, we are delighted to bring the expected benefits of Identify RevElate Accounting from patients to our patients and staff.

The revenue cycle continues to be one of Cerner’s largest annual intellectual property investment areas, and Identify RevElate is one of the results of a focused review of the company’s technology architecture and product portfolio led by CTO Jérôme Labat. “Cerner was a pioneer in the initial wave of healthcare technology and has spent decades paving the way for a more connected and efficient revenue cycle. As the industry continues to undergo digital and data transformation, Cerner has also evolved to better meet the needs of healthcare organizations. We are proud to be able to provide the result of a very comprehensive and deliberate review of our technology architecture and product portfolio that aims to deliver maximum value to healthcare systems, ”said Labat.

Cerner plans to increase its current patient accounting customer base to Identify RevElate in phases. To ease the transition, Cerner will strive to prepare clients while creating a personalized resource and implementation timeline. For more information, visit Cerner.com/revelate.

About Cerner

Cerner’s health technologies connect people and information systems to thousands of contracted provider facilities around the world dedicated to creating smarter, better care for individuals and communities. Recognized worldwide for its innovation, Cerner helps clinicians make care decisions and assists organizations in managing the health of their populations. The company also offers a connected clinical and financial ecosystem to help manage day-to-day revenue functions, as well as a wide range of services to meet people-centered clinical, financial and operational needs. For more information, visit Cerner.com, The Cerner Blog, or connect to Facebook, Instagram, LinkedIn, Twitter, or The Cerner Podcast. Nasdaq: CERN. Health is too important to stay the same.

All statements in this press release that do not directly and exclusively relate to historical facts constitute forward-looking statements. These forward-looking statements are based on the current beliefs, expectations and assumptions of Cerner’s management regarding future events and are subject to a number of important risks and uncertainties. It is important to note that Cerner’s performance, actual results, financial condition or business could differ materially from those expressed in these forward-looking statements. The words “will”, “plans”, “expected”, “intended” and “planning” or the negative of these words, variations thereof or similar expressions are intended to identify these forward-looking statements. For example, our forward-looking statements include statements regarding the benefits of Cerner RevElate, the expected value to be realized by customers and prospects and Cerner plans to elevate current customers. Factors that could cause or contribute to such differences include, without limitation, the possibility of disruption in our data centers or customer support facilities, or those of third parties with whom we have contracted (such as suppliers public cloud), which could expose us to significant costs and damage to reputation; the possibility of increased expenses, exposure to legal and regulatory actions and reputational damage associated with a cyber attack or other breach of our IT security or the IT security of third parties on which we count; potential claims for system errors and warranties or for significant costs and reputational damage related to product and service liabilities; material adverse resolution of legal proceedings or other claims or damage to reputation resulting from negative publicity relating to such claims or legal proceedings material competition and our ability to anticipate or respond quickly to changes in the market, changing technologies and evolving pricing and deployment methods and bringing new solutions, devices, features and services to market in a timely manner; risks related to our reliance on strategic relationships and third party vendors, including any impact on such vendor’s business resulting from the COVID-19 pandemic; risks associated with the loss or recruitment and retention of key personnel, failure to develop and successfully execute succession planning to ensure the transitions of key associates and their knowledge, relationships and expertise political influences, economic and regulatory changes, which could impact the purchasing practices and operations of our customers and increase the costs of providing compliant solutions and services; failure to comply with laws, regulations or certain industry initiatives or failure to provide solutions or services that enable our customers to comply with laws or regulations applicable to their business; risks inherent in contracting with government clients, including, without limitation, adherence to strict compliance and disclosure obligations. The reader should not place undue reliance on forward-looking statements, as statements speak only as of the date on which they are made. Except as required by law, Cerner assumes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unforeseen events or changes in our business, results of operations or our financial situation over time.

Media contact:
Stephanie Greenwood, Media Relations, [email protected]


Source link